Melphalan flufenamide

Pepaxti

polvere per concentrato e soluzione per soluzione per infusioneItalyAuthorised

In other countries

The same active substances on other registers, the same brand first.

Pepaxti 20 MG Polvo Para Concentrado Para Solucion Para PerfusionSpain · 21,48 mg · polvo para concentrado para solución para perfusión · Oncopeptides AbSame brand
PepaxtiEuropean Union · Oncopeptides AB (publ)Same brand
PepaxtiCroatiaSame brand
Pepaxti 20 mg, poeder voor concentraat voor oplossing voor infusieNetherlands · Poeder voor concentraat voor oplossing voor infusie · Oncopeptides ABSame brand

Packs

Pack	Code	Status
20 mg - Polvere per concentrato per soluzione per infusione - Uso endovenoso - Flaconcino (vetro) - 1 flaconcino	050299015	Autorizzata

Documents

The official texts, at the regulator.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Melphalan flufenamide

Pepaxti

polvere per concentrato e soluzione per soluzione per infusioneItalyAuthorised

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Packs

Pack	Code	Status
20 mg - Polvere per concentrato per soluzione per infusione - Uso endovenoso - Flaconcino (vetro) - 1 flaconcino	050299015	Autorizzata

Documents

The official texts, at the regulator.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Summary of product characteristicsAIFA

Package leafletAIFA

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agenzia Italiana del Farmaco (AIFA), Italy

Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.

Licence: CC BY 4.0; AIFA published open-data catalog · Added 13 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Melphalan flufenamide
Dosage form: polvere per concentrato e soluzione per soluzione per infusione
Register: Italy (AIFA)
Status: Authorised
Status in the register: Autorizzata
Registration: AIC 050299
Marketing authorisation holder: Oncopeptides AB
ATC code: L01AA10
Group: Antineoplastic and immunomodulating agents
Procedure: Procedura Centralizzata
Supply: Medicinali soggetti a prescrizione medica limitativa, utilizzabili esclusivamente in ambiente ospedaliero o in una struttura ad esso assimilabile